astrazeneca glp 1 signs up to US$18.5 billion obesity drug deal with China's CSPC Blockbuster ambitions grow as AstraZeneca
Pay in 4 interest-free payments of $5.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
Blockbuster ambitions grow as AstraZeneca moves oral GLP 1 into pivotal studies AstraZeneca's ECC5004: Pioneering oral GLP 1RA in obesity care AstraZeneca's elecoglipron just posted some of the most closely watched Phase IIb data of the year and it landed at the right conference. Results from the VISTA and SOLSTICE trials, published simultaneously Elecoglipron: AstraZeneca's Oral GLP1 Pill Hits 11.8% Weight Loss ADA 2026 Phase 2b Breakdown AstraZeneca Targets Obesity Market with Potential $2B Deal for Early GLP 1 Candidate BioSpace
Store: live-language.pl · Domain: live-language.pl


























